Zoetis reports Q3 adjusted EPS $1.70, consensus $1.62

Reports Q3 revenue $2.4B, consensus $2.41B. “We reported 4% organic operational revenue growth and 9% growth in adjusted net income on an organic operational basis, thanks to the relentless focus and consistent execution of our colleagues across the world,” said Kristin Peck, Chief Executive Officer of Zoetis (ZTS). “While growth moderated in the third quarter in line with our expectations, we achieved significant regulatory milestones, including major new product approvals, geographic expansions and differentiating lifecycle innovations across products and species. With our manufacturing excellence, strong customer relationships and a robust pipeline, we are well positioned to advance animal care, bring new products to market and deliver sustainable growth and value for our shareholders.”